{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:01:27Z","timestamp":1790395287258,"version":"4.1.0"},"reference-count":16,"publisher":"Japanese Circulation Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2026,9,25]]},"DOI":"10.1253\/circj.cj-26-0316","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:11:10Z","timestamp":1787782270000},"page":"1351-1357","source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Effectiveness and Safety of Direct Oral Anticoagulants in Japanese Patients With Venous Thromboembolism\u3000\u2015 Extended Follow-up Results From the KUROSIO Study \u2015"],"prefix":"10.1253","volume":"90","author":[{"given":"Michihisa","family":"Umetsu","sequence":"first","affiliation":[{"name":"Department of Surgery, Tohoku University Hospital"},{"name":"Department of Education and Support for Regional Medicine, Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ohashi Hospital, Toho University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuyuki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Hospital Organization Okayama Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Yuzaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Wakayama Saiseikai Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Sata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Yumoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yokohama Rosai Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Maemura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Ogihara","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Clinical Research Support Center, Mie University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Ogura","sequence":"additional","affiliation":[{"name":"Clinical Research Support Center, Mie University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Intensive Care, Nippon Medical School Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirono","family":"Satokawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Fukushima Medical University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Obayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Musashino Red Cross Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Tamaru","sequence":"additional","affiliation":[{"name":"Clinical Research Support Center, Mie University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikazu","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kuwana City Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashio","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Hidamarinooka Nakamura Medical Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the KUROSIO Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Yamashita Y, Fukasawa T, Takeda C, Takeuchi M, Ono K, Kawakami K. Clinical characteristics and outcomes of patients with venous thromboembolism receiving edoxaban in the real world. <i>Circ J<\/i> 2024; 88: 371\u2013379, doi:10.1253\/circj.CJ-23-0818.","DOI":"10.1253\/circj.CJ-23-0818"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Kaneda K, Yamashita Y, Morimoto T, Chatani R, Nishimoto Y, Ikeda N, et al. Anticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulants. <i>Eur J Intern Med<\/i> 2023; 118: 59\u201372, doi:10.1016\/j.ejim.2023.08.007.","DOI":"10.1016\/j.ejim.2023.08.007"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Nakamura M, Tamaru S, Hirooka S, Hirayama A, Tsuji A, Hirata M, et al. Efficacy and safety of warfarin for the treatment of venous thromboembolism: A multicenter prospective observational cohort study in Japan (AKAFUJI study). <i>Circ J<\/i> 2024; 88: 359\u2013368, doi:10.1253\/circj.CJ-23-0158.","DOI":"10.1253\/circj.CJ-23-0158"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Goto H, Umetsu M, Akamatsu D, Sugawara H, Tsuchida K, Yoshida Y, et al. Comparison of edoxaban and warfarin for the treatment of cancer-associated venous thromboembolism: A retrospective observational study. <i>Circ J<\/i> 2024; 88: 251\u2013258, doi:10.1253\/circj.CJ-20-0713.","DOI":"10.1253\/circj.CJ-20-0713"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Umetsu M, Yamaki T, Ogawa T, Nishibe T, Shiraishi Y, Yamada N, et al. Treatment and prevention of deep vein thrombosis in the DOAC era: Japanese Vein Study XXVI: A questionnaire survey. <i>Jpn J Phlebol<\/i> 2025; 36: 347\u2013354, doi:10.7134\/phlebol.25-06.","DOI":"10.7134\/phlebol.25-06"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Yamada N, Tamaru S, Umetsu M, Tsujita K, Nakamura M, Watanabe A, et al. Efficacy and safety of non-vitamin K antagonist oral anticoagulants for Japanese patients with venous thromboembolism: The primary results from the KUROSIO study. <i>Circ J<\/i> 2024; 88: 1672\u20131678, doi:10.1253\/circj.CJ-23-0954.","DOI":"10.1253\/circj.CJ-23-0954"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Nakamura M, Yamada N, Asamura T, Shiosakai K, Uchino K. Safety and effectiveness of edoxaban in Japanese venous thromboembolism patients: Final analysis of one-year follow-up data from a Japanese postmarketing observational study (ETNA-VTE-Japan). <i>Circ Rep<\/i> 2020; 2: 192\u2013202, doi:10.1253\/circrep.CR-19-0127.","DOI":"10.1253\/circrep.CR-19-0127"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Yamada N, Mo M, Ohsawa A, Sato M, Umeyama M, Shima D, et al. Safety and effectiveness of apixaban in Japanese patients with venous thromboembolism in clinical practice: A post-marketing surveillance. <i>Circ J<\/i> 2021; 85: 2201\u20132207, doi:10.1253\/circj.CJ-20-0829.","DOI":"10.1253\/circj.CJ-20-0829"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Okumura Y, Fukuda I, Nakamura M, Yamada N, Takayama M, Maeda H, et al. A multicenter prospective observational cohort study to investigate the effectiveness and safety of rivaroxaban in Japanese venous thromboembolism patients (the J\u2019xactly study). <i>Circ J<\/i> 2020; 84: 1912\u20131921, doi:10.1253\/circj.CJ-20-0636.","DOI":"10.1253\/circj.CJ-20-0636"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. <i>J Thromb Haemost<\/i> 2005; 3: 692\u2013694, doi:10.1111\/j.1538-7836.2005.01204.x.","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"11","unstructured":"11. Tamura Y. JCS\/JPCPHS 2025 Guideline on the management of pulmonary thromboembolism, deep venous thrombosis, and pulmonary hypertension [in Japanese]. 2025. https:\/\/www.j-circ.or.jp\/cms\/wp-content\/uploads\/2025\/03\/JCS2025_Tamura.pdf (accessed February 2, 2026)."},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Yamashita Y, Morimoto T, Muraoka N, Oyakawa T, Umetsu M, Akamatsu D, et al. Edoxaban for 12 months versus 3 months in patients with cancer with isolated distal deep vein thrombosis (ONCO DVT study): An open-label, multicenter, randomized clinical trial. <i>Circulation<\/i> 2023; 148: 1665\u20131676, doi:10.1161\/circulationaha.123.066360.","DOI":"10.1161\/CIRCULATIONAHA.123.066360"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Miyoshi Y, Yamashita Y, Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, et al. Impact of thrombocytopenia in patients with cancer-associated isolated distal deep vein thrombosis treated with edoxaban for 12 months versus 3 months: Insights from the ONCO DVT study. <i>Thromb Res<\/i> 2025; 253: 109419, doi:10.1016\/j.thromres.2025.109419.","DOI":"10.1016\/j.thromres.2025.109419"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Kobayashi S, Ogihara Y, Yamashita Y, Morimoto T, Chatani R, Kaneda K, et al. Low body weight and long-term outcomes in patients with venous thromboembolism: Insights from the COMMAND VTE Registry-2. <i>Thromb Haemost<\/i> 2025, doi:10.1055\/a-2760-8218.","DOI":"10.1055\/a-2760-8218"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Ikeda S, Yamashita Y, Morimoto T, Ueno Y, Maemura K, Chatani R, et al. Prediction score for major bleeding in patients with venous thromboembolism receiving direct oral anticoagulants: Insights from the COMMAND VTE Registry-2. <i>Circ J<\/i> 2025; 89: 1896\u20131905, doi:10.1253\/circj.CJ-25-0186.","DOI":"10.1253\/circj.CJ-25-0186"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Hara T, Sata M. Current real-world status of oral anticoagulant management in Japanese patients. <i>Circ J<\/i> 2025; 89: 150\u2013152, doi:10.1253\/circj.CJ-24-0827.","DOI":"10.1253\/circj.CJ-24-0827"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/10\/90_CJ-26-0316\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:28:18Z","timestamp":1790393298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/10\/90_CJ-26-0316\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-26-0316","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"CJ-26-0316"}}